Geneva, April 20 -- International Clinical Trials Registry received information related to the study (NCT07513207) titled 'A Study in Healthy People to Test How Vicadrostat Affects the Heart' on April 1.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Crossover Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: Boehringer Ingelheim
Condition:
Healthy
Intervention:
Drug: Vicadrostat
Drug: Placebo matching Vicadrostat
Recruitment Status: Not recruiting
Phase: Phase 1
Date of First Enrollment: April 22, 2026
Target Sample Size: 45
Countries of Recruitment:
Germany
To know more, visit https://clinicalt...